Same Indication

Metformin vs Osimertinib

Metformin vs Osimertinib: Overview

This comparison examines the pharmacological differences between Metformin and Osimertinib.

Mechanism of Action

Metformin: Activates AMP-activated protein kinase, decreasing hepatic glucose production.

Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

Pharmacokinetics

Half-life: Metformin — 4-9 hours; Osimertinib — 48 hours.

Chemical Properties

Molecular Formula: Metformin — C4H11N5; Osimertinib — C28H33N7O2.

Molecular Weight: Metformin — 129.1640 g/mol; Osimertinib — 499.6050 g/mol.

Type: Metformin — Small molecule; Osimertinib — Small molecule.